JOIN to get FREE Delivery
Provide Delivery Location
Hepcinat-Lp Tablet 28'S belongs to a class of drugs called antivirals. It is used to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C virus infection is a severe liver infection caused by the hepatitis C virus (HCV). It is contagious (spreads from one person to another) and spreads through contact with the infected person’s blood.
Hepcinat-Lp Tablet 28'S contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing. Thus, the infection can be completely eliminated from the body.
Hepcinat-Lp Tablet 28'S should be taken as prescribed by the doctor. In some cases, Hepcinat-Lp Tablet 28'S may cause common side effects such as headache, tiredness, rash, dizziness, muscle pain, irritability, diarrhea, and angioedema (swelling). Most of these side effects of Hepcinat-Lp Tablet 28'S do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to ledipasvir, sofosbuvir, or any of the other ingredients in this medication, do not take it. Inform your healthcare professional about your medical conditions before taking Hepcinat-Lp Tablet 28'S, especially if you have liver problems other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus or kidney problems or are on kidney dialysis, or are receiving ongoing HIV treatment; your doctor may want to monitor you more closely.
Hepcinat-Lp Tablet 28'S used to treat chronic (long-term) hepatitis C virus infection in adults and children 3 years of age and older. Hepcinat-Lp Tablet 28'S contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing. Thus, the infection can be completely eliminated from the body.
Please tell your doctor if you are allergic to Sofosbuvir or other medicines. Additional monitoring is required if you are currently taking antibiotics (rifampicin and rifabutin); herbal medicine used to treat depression (St. John’s wort); drugs used to treat epilepsy and prevent seizures (carbamazepine and phenobarbital); a medication used to treat high cholesterol (rosuvastatin), medicine to treat irregular heartbeats (amiodarone), so inform your doctor before taking Hepcinat-Lp Tablet 28'S. Avoid pregnancy during treatment with Hepcinat-Lp Tablet 28'S as it may harm the unborn baby when used in combination with ribavirin. You or your partner must use an effective birth control method during and after this treatment. However, contact your doctor immediately if you become pregnant during therapy or in the months following your treatment with Hepcinat-Lp Tablet 28'S. You are advised to take proper precautions if you are infected with the hepatitis C virus infection to prevent the spread of infection to others.
Drug-Drug Interactions: Hepcinat-Lp Tablet 28'S may interact with antibiotics (e.g. rifampicin, rifabutin), herbal medicine used to treat depression (St. John’s wort), drugs used to treat epilepsy and prevent seizures (e.g. carbamazepine, phenobarbital), a medicine used to treat high cholesterol (e.g. rosuvastatin), and the medicine to treat irregular heartbeats (e.g. amiodarone).
Drug-Food Interactions: Avoid the consumption of alcohol.
Drug-Disease Interactions: If you have diabetes or liver problems other than hepatitis C (if you are awaiting liver transplantation), kidney problems, or if you are on kidney dialysis or heart problems, inform your doctor before taking Hepcinat-Lp Tablet 28'S.
Hepatitis C: It is a severe liver infection caused by the hepatitis C virus (HCV). It is contagious (spreads from one person to another) and spreads through contact with the infected person’s blood, sharing needles, using a razor or any other personal items or even transfer from mother to baby during birth. The symptoms may not appear immediately. Some may take between 2 to 12 weeks to appear. Few people may have mild to moderate symptoms such as dark urine, loss of appetite, fever, joint pain, or stomach discomfort. The complications of untreated chronic hepatitis C include liver cancer or liver cirrhosis (scarring).
Alcohol
Caution
The interaction of alcohol with Hepcinat-Lp Tablet 28'S is unknown. However, as a precautionary measure, consumption of alcohol should be avoided.
Pregnancy
Caution
It is unknown how Hepcinat-Lp Tablet 28'S will affect a pregnant woman. See your doctor before using this medication if you are pregnant, suspect you might be pregnant, or intend to become pregnant. Pregnancy must be avoided if Hepcinat-Lp Tablet 28'S is taken together with ribavirin. It is crucial that you carefully read the ribavirin package leaflet's 'Pregnancy' section. An unborn child may suffer significant harm from ribavirin. Therefore, if there is a chance that sexual activity will result in pregnancy, extra precautions must be taken.
Breast Feeding
Caution
Do not breastfeed during treatment with Hepcinat-Lp Tablet 28'S. The two active ingredients in Harvoni, ledipasvir and sofosbuvir, are unknown to enter human breast milk.
Driving
Caution
If you feel tired after taking Hepcinat-Lp Tablet 28'S, you should not participate in activities requiring concentration; for example, do not drive, ride a bike or operate machines.
Liver
Caution
Inform your doctor if you have liver problems before taking Hepcinat-Lp Tablet 28'S; your doctor will weigh the benefits and potential risks before prescribing Hepcinat-Lp Tablet 28'S based on your liver conditions.
Kidney
Caution
Hepcinat-Lp Tablet 28'S has not been fully tested in patients with severe kidney problems. So, inform your doctor if you have kidney problems before taking Hepcinat-Lp Tablet 28'S. your doctor will weigh the benefits and potential risks before prescribing Hepcinat-Lp Tablet 28'S.
Children
Safe if prescribed
Hepcinat-Lp Tablet 28'S is given to treat chronic (long-term) hepatitis C virus infection in children three years of age and older. If you have any concerns regarding the use of Hepcinat-Lp Tablet 28'S in children, discuss them with your doctor.
We provide you with authentic, trustworthy and relevant information